Financial News · Live Terminal

Page 20 of 413

Raymond James Initiates Faeth Therapeutics at Outperform

Faeth Therapeutics (FTH) has an average rating of buy and mean price target of $54.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Financial News · Live Terminal

Raymond James Initiates Faeth Therapeutics at Outperform

BMO Capital Upgrades Nextpower to Outperform From Market Perform, Price Target is $132

Baird Initiates HeartFlow at Outperform With $34 Price Target

Roth Capital Initiates Sky Harbour Group at Buy With $14 Price Target

Deutsche Bank Downgrades Roblox to Hold From Buy, Adjusts Price Target to $38 From $56

Citigroup Initiates BBB Foods at Buy With $49 Price Target

Wedbush Downgrades Roblox to Neutral From Outperform, Cuts Price Target to $40 From $65, Cites 'Near-Zero Visibility'

Evans & Partners Downgrades Ampol to Neutral from Positive; Price Target is AU$41

CICC Starts Shanghai Xizhi Technology at Outperform with HK$362 Price Target

UBS Downgrades China Gas to Neutral from Buy; Price Target is HK$6.80

Barrenjoey Downgrades Domino's Pizza Enterprises to Neutral from Overweight; Price Target is AU$21

Barrenjoey Upgrades Boss Energy to Neutral from Underweight; Price Target is AU$1.40

Macquarie Downgrades Sonic Healthcare to Neutral from Outperform; Price Target is AU$23.60

Phillip Securities Upgrades Fuji Electric to Buy from Neutral; Price Target is 15,300 Yen

Kasikorn Securities Downgrades WHA Premium Growth Freehold & Leasehold Real Estate Investment Trust to Neutral from Outperform; Price Target is THB11.20

Kasikorn Securities Downgrades Bangkok Commercial Asset Management to Neutral from Outperform; Price Target is THB6.90

RBC Downgrades Ampol to Sector Perform from Outperform; Price Target is AU$40

Okasan Securities Starts Shimamura at Neutral with 3,600 Yen Price Target

Masterlink Securities Upgrades Holtek Semiconductor to Buy from Hold; Price Target is NT$60

Fubon Securities Upgrades Flexium Interconnect to Buy from Neutral; Price Target is NT$61

Raymond James Initiates Faeth Therapeutics at Outperform

BMO Capital Upgrades Nextpower to Outperform From Market Perform, Price Target is $132

Baird Initiates HeartFlow at Outperform With $34 Price Target

Roth Capital Initiates Sky Harbour Group at Buy With $14 Price Target

Deutsche Bank Downgrades Roblox to Hold From Buy, Adjusts Price Target to $38 From $56

Citigroup Initiates BBB Foods at Buy With $49 Price Target

Wedbush Downgrades Roblox to Neutral From Outperform, Cuts Price Target to $40 From $65, Cites 'Near-Zero Visibility'

Evans & Partners Downgrades Ampol to Neutral from Positive; Price Target is AU$41

CICC Starts Shanghai Xizhi Technology at Outperform with HK$362 Price Target

UBS Downgrades China Gas to Neutral from Buy; Price Target is HK$6.80

Barrenjoey Downgrades Domino's Pizza Enterprises to Neutral from Overweight; Price Target is AU$21

Barrenjoey Upgrades Boss Energy to Neutral from Underweight; Price Target is AU$1.40

Macquarie Downgrades Sonic Healthcare to Neutral from Outperform; Price Target is AU$23.60

Phillip Securities Upgrades Fuji Electric to Buy from Neutral; Price Target is 15,300 Yen

Kasikorn Securities Downgrades WHA Premium Growth Freehold & Leasehold Real Estate Investment Trust to Neutral from Outperform; Price Target is THB11.20

Kasikorn Securities Downgrades Bangkok Commercial Asset Management to Neutral from Outperform; Price Target is THB6.90

RBC Downgrades Ampol to Sector Perform from Outperform; Price Target is AU$40

Okasan Securities Starts Shimamura at Neutral with 3,600 Yen Price Target

Masterlink Securities Upgrades Holtek Semiconductor to Buy from Hold; Price Target is NT$60

Fubon Securities Upgrades Flexium Interconnect to Buy from Neutral; Price Target is NT$61